Original article
Drug cost avoidance in prostate cancer clinical trials
Coste evitado en medicamentos de ensayos clínicos en cáncer de próstata
M. Calvin-Lamasa,
, P. Portela-Pereirab, M.T. Rabuñal-Alvareza, S. Martinez-Breijob, M.I. Martín-Herranza, F. Gómez-Veigab,c
Corresponding author
a Servicio de Farmacia, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC) , A Coruña, Spain
b Servicio de Urología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña, Spain
c Servicio de Urología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL) , Salamanca, Spain
Read
26
Timeswas read the article
4
Total PDF
22
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 March | 1 | 0 | 1 |
| 2018 February | 1 | 1 | 2 |
| 2018 January | 4 | 0 | 4 |
| 2017 December | 4 | 0 | 4 |
| 2017 November | 11 | 0 | 11 |
| 2016 February | 0 | 1 | 1 |
| 2015 December | 0 | 1 | 1 |
| 2015 November | 1 | 1 | 2 |
